PodCAST-PCI: Colchicine Given Pre-PCI Does Not Reduce No-Reflow Phenomenon in PCI Patients Versus Placebo
Colchicine did not significantly reduce the rate of no-reflow phenomenon (NRP) or improve cardiovascular outcomes when administered immediately before primary percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (STEMI) according to follow-up over 1 year in the PodCAST-PCI trial.